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Summary L-Glutamine is a requirement for many cells in tissue culture, an intermediate in many metabolic
pathways, and an alternative substrate to glucose for energy metabolism. These properties suggest that
glutamine concentration might be a determinant of cell viability in tumours, especially in regions that are
deficient in other metabolites. We have therefore studied the effects of glutamine depletion on single cells in
culture, on spheroids and on experimental tumours.
Absence of glutamine suppressed the growth rate of two cell lines, but cells cultured for up to 6h in the
absence of glutamine had no decrease in plating efficiency. There was little effect on growth of MGH-U1
(human bladder cancer) spheroids of varying the glutamine concentration in the range of 0.1 to 2mM and
spheroids exposed to these concentrations did not develop central necrosis. Lower concentration of glutamine
suppressed the rate of spheroid growth, and spheroids did not grow in the absence of glutamine. Pseudomonas
7A glutaminase reduced the survival ofcells in glutamine-free culture and prevented growth of spheroids.
Glutaminase was injected into mice bearing experimental tumours to reduce blood levels of glutamine;
some animals also received 15Gy radiation to their tumours to assess the effects of glutamine levels on
surviving nutrient-deprived (i.e. hypoxic) cells. Glutaminase had no effect on cell survival in the Lewis lung
tumour or in MGH-Ul xenografts, with or without radiation; glutaminase caused dose-dependent growth
delay of the KHT tumour, which was additive to that caused by radiation. The present results suggest that (i)
short-term changes of glutamine concentration have small effects on cell viability; and (ii) depletion of
glutamine levels in blood through the in vivo use of glutaminase is unlikely to produce major therapeutic
effects against nutrient-deprived cells in solid tumours.
Solid tumours frequently have a high rate of cell
death and necrosis, but the causes of cell death
remain poorly understood. The observation in both
human and murine tumours that the edge of a
necrotic region may be parallel to its nearest blood
vessel (Thomlinson & Gray, 1955; Tannock,
1968,1970; Moore et al., 1985) suggests strongly
that limited penetration of nutrient metabolites
and/or limited clearance of toxic catabolites may be
important factors in the causation of cell death.
Spheroids are multi-cellular spherical aggregates of
tumour cells that grow in spinner culture and which
may develop central necrosis (Sutherland et al.,
1971). Variation of the concentration of essential
metabolites in the medium surrounding spheroids
provides a useful model for studying potential
causes of cell death in tumours. Studies of this type
have suggested that limited penetration of both
oxygen and glucose may contribute to central
necrosis (Franko & Sutherland, 1979; Mueller-
Klieser et al., 1986; Tannock & Kopelyan 1986a,b).
It is probable, however, that the concentration of
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other important metabolites decreases with
increasing distance from tumour blood vessels, and
that limited supply of several metabolites may
contribute to cell death. One metabolite which
might be expected to play a critical role in
maintaining cell viability is L-glutamine.
L-glutamine is an essential requirement for
growth of many types of cells in tissue culture, and
a concentration of glutamine in the range of 0.2-
1.0mM is required in medium to give optimal
growth of cells; this is tenfold higher than the
requirement for most other amino acids (Eagle et
al., 1956). Glutamine is a precursor for de novo
purine and pyrimidine biosynthesis, and changes in
the ratio of activities of enzymes required for
glutamine synthesis and metabolism have been
reported in several tumours (Weber, 1983).
Glutamine is also an alternative substrate to
glucose for metabolism to pyruvate and production
of high energy phosphates; it has been reported to
be an important substrate for energy metabolism in
tumours and several normal tissues (Windmueller &
Spaeth, 1978; McKeehan, 1982; Sauer et al., 1982).
Many tumours have low levels of glutamine as
compared to normal tissues, with lower levels
reported in rapidly growing tumours (Pine, 1983;
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Sebolt & Weber, 1984). Glutamine is the most
abundant amino acid in blood, and low levels in
tumours are probably due to the high rate of
utilization that has been measured within them
(Sauer et al., 1982). The central role of glutamine in
tumour metabolism, and its high rate of utilization
by tumours suggests that very low levels might
occur in some tumour regions that are distant from
blood vessels. Low levels of glutamine might
therefore contribute to cell death and necrosis in
tumours.
An understanding of nutrient factors which
influence the viability of tumour cells is not only of
biological importance, but might also suggest new
approaches to therapy. Nutrient-deprived cells in
tumours are resistant to radiation (because of
hypoxia), and to some anticancer drugs (because of
limited drug penetration, slow rate of proliferation,
or other cause). If the viability of nutrient-deprived
cells in tumours were found to be critically
dependent on glutamine concentration, such cells
might be selectively killed by using glutaminase to
deplete glutamine levels in blood (and hence lower
its penetration into tissue). We have therefore
performed experiments to assess the role of
glutamine in maintaining the viability of cells in
monolayer culture, in spheroids, and in experi-
mental tumours.
Materials and methods
Tissue culture
Experiments were performed with Chinese hamster
ovary (CHO) cells and with the human bladder
cancer MGH-Ul cell line. MGH-U1 cells have been
characterized by karyotyping and isoenzyme
analysis; this cell line is of identical origin to the
cell lines designated EJ and T24 (O'Toole et al.,
1983) and contains an activated Ha-ras oncogene.
The cell lines were cultured as monolayers in a-
medium+10% foetal calf serum (FCS). a-medium
contains 2mM glutamine, 0.5mM glutamic acid,
and 5.5mM glucose. For studies of cell growth and
viability a (-)-medium was prepared without these
nutrients, and FCS was dialyzed against 40:1
NaCl:KCl with phosphate buffer to remove these
and other small molecules. Known amounts of
glutamine or other nutrients were then added to
this medium.
Growth of cells in monolayer was studied by
detaching cells in exponential growth and seeding
known numbers (usually 105) into identical flasks
containing medium with varying concentration of
glutamine (and/or glutamic acid). At intervals
thereafter flasks were selected at random, and the
cells were detached and counted using a Coulter
counter. Cell counts from some cultures were
verified by using a hemocytometer, but the two
estimates of cell number were always in close
agreement.
For studies of plating efficiency, cells were
cultured in a stirred suspension at a concentration
of 106ml-I in medium deficient in various meta-
bolites. At various times cells.were aspirated from
the suspension, washed, and plated in Petri dishes
countaining a-medium +10% FCS. Colonies were
stained and counted in triplicate dishes about 10
days later.
In some experiments, exponentially growing cells
in monolayer were exposed to Pseudomonas 7A
glutaminase (Roberts, 1976). Following exposure,
cells were detached, washed and plated in Petri
dishes as described above.
Spheroids
A subline of MGH-Ul cells has been developed
which spontaneously generates spheroids when
placed in spinner culture (Erlichman & Tannock,
1986; Tannock & Kopelyan, 1986a). For study of
spheroid growth in varying concentrations of
glutamine, spheroids of uniform size (- 400pm
diameter) were selected from spinners and placed
one per well in 24-well multiwell plates. The wells
contained an underlayer consisting of 0.5ml 1.5%
agar, diluted in a(-)-medium, and 2ml of liquid
medium containing the specified concentration of
glutamine. One ml of liquid was aspirated and
replaced with fresh medium every 2 days. Spheroid
growth was monitored by removing briefly the
multiwell plate (protected by a transparent cover)
from the incubator at 1-3 day intervals. The plate
was placed on the stage of an inverted microscope,
and the maximum and orthogonal diameter of each
spheroid were then measured using an eyepiece
reticule. The mean diameter of multiple spheroids
was then plotted against time to generate a growth
curve.
Spheroids were examined histologically for the
presence of necrosis. In some experiments spheroids
were pipetted from the multiwells and frozen
sections were cut and stained with hematoxylin and
eosin. In other experiments spheroids were exposed
to mercurochrome to facilitate recognition, and
fixed overnight in Bouin's solution. Fixed spheroids
were embedded sequentially in 1.5% agar and
paraffin wax, followed by serial sectioning and
staining. The procedure gives high quality sections,
but leads to an estimated 21% shrinkage in linear
dimension.
Tumours
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sarcoma, the Lewis lung tumour, and MGH-Ul
xenografts. The KHT tumour was maintained by
serial transplantation in syngeneic C3H mice, with
periodic re-establishment from frozen stock. For
generation of tumours to be used in experiments, a
cell suspension was prepared by mechanical means,
and 105 cells were injected into the muscle of the
left hind leg. The Lewis lung tumour, obtained
originally from the National Cancer Institute
tumour bank, USA, was passaged alternately as
tumours in syngeneic C57/Bl mice, and as mono-
layer culture. Firmly adherent cells were selected at
each passage in culture, leading to selection of cells
that formed closely packed colonies on plating.
Experimental Lewis lung tumours were generated as
described for the KHT tumours. MGH-Ul
xenografts were generated by injecting _106 cells,
maintained in culture, into the left hind legs of
immune-deprived CBA/CAJ mice. Mice were
immune-suppressed by thymectomy, and treatment
with cytosine arabinoside and whole body
irradiation (Steel et al., 1978; Kovnat et al., 1982).
Animals bearing tumours were treated with
Pseudomonas 7A glutaminase by i.p. injection,
usually given as 4 injections at daily intervals.
Controls received either saline or heat-inactivated
glutaminase. Some groups of animals also received
radiation to their tumours, delivered from a
specially constructed double-headed 250 kVp X-ray
machine at a dose rate of - 11.4Gymin-1.
Animals irradiated in air were lead shielded during
irradiation without anaesthesia, and the tumour-
bearing leg was taped in the radiation field. Radiation
was delivered at least 1 h after glutaminase
injection on the third day of such injections; if
glutaminase led to the death of nutrient-deprived
and hypoxic cells this schedule should have allowed
radiation effects to be directed against surviving'
aerobic cells. Some groups of animals received
radiation to their KHT tumour under hypoxic
conditions: this was achieved by applying a clamp
to the tumour-bearing leg of anaesthetized mice for
5 min prior to and during radiation, as described
previously (Tannock, 1982).
Response of the KHT tumour to treatment was
assessed in coded animals by delay in tumour
growth, as described previously (Tannock, 1982).
Response of the Lewis lung tumour and of
MGH-U1 xenografts was assessed by clonogenic
assay. Animals were killed and their tumours were
removed 2h after the last injection of glutaminase
(about 24h after radiation, in animals that received
this treatment). The tumour was removed, chopped
coarsely with scissors, and then stirred in 0.05%
trypsin in calcium-free PBS for 30min. This
procedure led to a suspension of single cells with
high viability and serial dilutions were plated in
triplicate Petri dishes. Stained colonies were
counted about 10 days later.
Measurement ofglutamine concentration
The concentration of glutamine in medium or
serum was determined by using a modification of
the enzymatic method described by Pye et al.
(1978). Pooled serum from mice was deproteinized
using perchloric acid, which was added to give a
final pH of 3.0; we found that glutamine was
broken down if pH was allowed to fall to a lower
value. The method is based on the conversion of
glutamine to glutamic acid in the presence of
glutaminase, followed by oxidation of glutamic acid
in the presence of glutamate dehydrogenase, NAD,
and ADP. The second reaction leads to the
reduction of NAD to NADH which was measured
with a fluorescence spectrometer (Perkin-Elmer
model LS-3) using excitation and emission wave-
lengths of 350nm and 460nm respectively. This
method allows the measurement of concentration
of both glutamine and glutamic acid. Comparison
of repeated estimates ofglutamine and glutamic acid
in known standard solutions indicated that the
method was accurate to within 50pM for each
amino acid.
Results
Single cells in culture
The growth of CHO and MGH-Ul cells in normal
a-medium, in the absence of glutamine, and in the
absence of both glutamine and glutamic acid is
shown in Figure 1. CHO cells were able to grow in
the absence of both amino acids, but their growth
rate was suppressed; the plating efficiency of CHO
cells taken from 5-day cultures without glutamine
and glutamic acid was <50%, as compared to 90%
in controls. Human MGH-Ul cells grew more
slowly under control conditions, and in duplicate
experiments showed minimal or no growth in the
absence ofglutamine.
Cell survival was assessed following culture of
CHO or MGH-U1 cells for up to 6h in various
types of deficient media. These experiments were
designed to assess the acute effects of nutrient
deprivation, as might occur in tumour cells that
migrate toward a region of necrosis (Tannock,
1968). The results of a representative experiment
are shown in Figure 2. Removal of glutamine with
or without glutamic acid, or removal of glucose or
oxygen alone had little effect on cell survival in
multiple experiments, and differences in plating736 I.F. TANNOCK et al.
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Figure 1 Growth curves for (A) CHO cells and (B) MGH-U1 human bladder cancer cells grown in
a-medium plus 10% dialyzed FCS, or in similar medium lacking glutamine+glutamic acid. Repeated
experiments were qualitatively similar, although growth rate of the cells varied among experiments.
efficiency under these conditions were not signi-
ficant. Medium deficient in glucose and glutamine
(the major substrates for energy metabolism) led to
some fall in cell survival over 6h; this fall in
survival was greater when cells were exposed to
nitrogen, thus depriving cells of the ability to use
the Krebs cycle. Under no conditions, however, did
nutrient deprivation lead to rapid killing of cells,
suggesting that many cells can maintain vital
functions for several hours in the absence of
substrates for energy metabolism.
Incubation of ax-medium at 37°C with 0.01 or
0.1 IUml - glutaminase at pH 7.2 led to a fall in
glutamine concentration to undetectable levels after
8 h or within 2h respectively (data not shown).
The influence of glutaminase on cell survival was
assessed following a 24h exposure of both CHO
and MGH-UI cells. The enzyme was added to
a-medium which either contained glutamine or was
glutamine free (Figure 3). CHO cells had no change
in plating efficiency after 24h in glutamine-free
medium. In the initial presence of glutamine (0.2 or
2mM), glutaminase concentrations of 0.01 to
0.1IUml-I led to only a small fall in cell survival
of CHO cells to the range of 70-90%, suggesting
minimal direct toxicity. There was a greater
reduction in survival (to 20%) in glutamine-free
medium. For MGH-U1 cells removal of glutamine
alone for 24h caused a fall in cell survival to about
30%, but additional toxicity of glutaminase was of
the same order as for CHO cells (data not shown).
Spheroids
MGH-U 1 spheroids showed a linear increase in
diameter of 80-100pm per day when grown under
control conditions (2mM glutamine). Spheroids
grew at the same rate as controls in glutamine
concentrations above 0.1 mM (data not shown), but
grew more slowly when the glutamine concentration
was reduced to 0.1 mM or below (Figure 4).
Spheroids did not grow in glutamine-free medium.
There was also no growth of spheroids in a-
medium containing 0.01 lUml-1 glutaminase,
regardless of whether or not glutamine was present
initially in the medium.
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Figure 2 Cell survival of MGH-Ul cells after culture
for 0-6h under various conditions of nutrient
deprivation. Mean and range are indicated for
triplicate plates.
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Figure 4 Growth of MGH-Ul spheroids in different
concentrations of glutamine. Mean + s.e. is indicated
for groups of at least 6 spheroids.
0
C._
Cu 0)
CM
cJ
En
Glutaminase concentration (IU ml-')
Figure 3 Cell survival of CHO cells following
incubation for 24h with varying concentrations of
Pseudomonas 7A glutaminase. Medium either
contained glutamine 2mM (O 0) or 0.2mM (A) or
was glutamine free, (V Y) prior to addition of
glutaminase. Open and closed symbols represent
results of independent experiments.
Histological sections of spheroids that had grown
in varying concentrations of glutamine (0, 0.05, 0.1
or 2mM) for 6-7 days were examined for the
presence of central necrosis. These spheroids had
mean diameters in the range of 400-1000 um,
depending on the glutamine concentration in which
they were grown, but there was no necrosis in any
of them. This result may be contrasted to previous
studies which have demonstrated extensive necrosis
in MGH-Ul spheroids cultured in glucose-deficient
medium (Tannock & Kopelyan, 1986a).
In vivo experiments
The toxicity of glutaminase, given as daily
injections for four days was studied in C3H and
C57 mice. Maximum tolerated doses were about
150IUkg1 day- I and 500IUkg-1 day-1 respec-
tively in tumour-bearing mice, although higher
doses were tolerated by C3H mice without
tumours. Mice bearing the KHT tumour showed an
increase of serum lactate dehydrogenase (LDH)
levels to - 20,000 IUml- 1 as compared to a mean
value of 2300 IUml 1 in conrols; this suggests that
the KHT tumour is infected with the LDH-
elevating virus which has been shown by others to
delay the clearance of glutaminase and to increase
its toxicity (Riley et al., 1974; Roberts et al., 1979).
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Figure 5 Cell survival in (A) Lewis lung tumours and (B) MGH-U1 human bladder cancer xenografts as a
function of radiation dose following treatment with radiation alone (closed symbols), or radiation plus
glutaminase (500IUkg 1 i.p. x 4 days; open symbols). Different symbols represent independent experiments,
and mean and range are indicated for triplicate plates. Both sets of data were fitted by single regression
analyses, for doses >4 Gy, and the resulting cell survival curves are characterized by (A) Do =3.1 Gy, ni=2.0,
and (B) Do =4.6Gy, n-= 1.8.
No increase in serum LDH was observed in C57
mice bearing the Lewis lung tumour, which
presumably lacks the virus.
Mean glutamine levels in the serum of C3H mice
were in the range of 0.3-0.4mM. Serum glutamine
levels at intervals after injection of 100 IUkg-1
glutaminase into C3H mice (without tumours) fell
rapidly to the range of 0-20% of concurrently
determined control values within 2h and remained
at low levels for 24h (data not shown).
Cell survival in Lewis lung tumours and MGH-
U1 xenografts following radiation alone, and after
radiation given on the third day of four glutaminase
injections are shown in Figure 5. Glutaminase
had no consistent effect on cell survival, either
when used alone or with radiation; this result
.implies no effect of glutaminase (and glutamine
depletion) on the hypoxic cells that survive
radiation treatment in this tumour.
Glutaminase did cause a dose-dependent increase
in growth delay of the KHT tumour. When used
with 15Gy radiation to the tumour, the increase in
growth delay caused by glutaminase was equal or
slightly greater to that caused by glutaminase alone
(Figure 6). In order to determine whether nutrient-
deprived and hypoxic cells that are spared by
radiation might be killed by glutamine depletion,
we administered glutaminase to animals that
received radiation to their tumours under either
aerobic or hypoxic conditions. Radiation delivered
under hypoxic conditions would be expected to kill
cells uniformly throughout the tumour and will not
therefore select a surviving population of nutrient-
deprived cells. There was a slightly larger effect of
glutaminase when used with radiation delivered
under aerobic as compared to hypoxic conditions
(data not shown), but the interaction of the drug
with either aerobic or hypoxic radiation was within
the range of additivity.
Discussion
We have studied the effects of glutamine
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Figure 6 Growth curves for the KHT tumour treated with (A) glutaminase alone, or (B) 15Gy irradiation
± glutaminase. The radiation was given on the third day of glutaminase injections. Mean + s.e. is indicated
for groups of 7-8 tumours.
deprivation on single cells in culture, on spheroids,
and on experimental tumours in order to provide
models of increasing complexity which might detect
an effect of glutamine depletion to interact with
deficiencies of other nutrients to cause cell death.
As reported by others (Eagle et al., 1956) we found
a cell line-dependent inhibition of growth under
conditions of glutamine deprivation in tissue
culture. Major effects to reduce cell viability during
a 6h incubation period were observed, however,
only when glucose and oxygen were also deficient.
These conditions are likely to suppress energy
metabolism by preventing access to the Krebs cycle
and oxidative phosphorylation, and by removing
glucose and glutamine as sources of carbohydrate
for glycolysis. We have shown previously that cell
culture in the absence of glucose and oxygen also
leads to loss of cell viability (although the effect is
larger when glutamine is also absent), and to a fall
in cellular ATP levels (Rotin et al., 1986).
Low levels of glucose, oxygen, and glutamine
might be expected to occur in the centre of multi-
cellular tumour spheroids, 0due to limited
penetration of these metabolites. We have shown
previously that growth of MGH-Ul spheroids is
reduced in medium deficient in glucose and/or
oxygen (Tannock & Kopelyan, 1986a,b) in
agreement with the results of others using different
types of spheroids (Franko & Sutherland, 1979;
Mueller-Klieser et al., 1986). Central necrosis is also
dependent on glucose and oxygen concentration in
the medium surrounding spheroids. Spheroid
growth was only influenced by glutamine concen-
tration below O.1 mM and spheroids did not
develop necrosis when grown in either normal or
glutamine-deficient medium. Thus, if spheroids are
an appropriate model for nodules in tumours, it
seems unlikely that glutamine levels are critical for
maintenance of cell viability, since blood concen-
tration is usually above 0.3 mM.
L-asparaginase is used clinically in the treatment
of lymphoid malignancies, and asparaginase-
glutaminase enzymes have been reported to exert
therapeutic effects against several experimental
tumours. These therapeutic effects were magnified
by the presence of LDH-elevating virus which was
found to delay the clearance of glutaminase (Riley
et al., 1974; Roberts et al., 1979). C3H mice
bearing the KHT tumour had elevated levels of
serum LDH suggesting that this tumour was
infected with the virus. There was no difference in
serum LDH levels in C57 mice with or without
Lewis lung tumours. The observation that glut-
aminase led to anti-tumour effects against the
KHT, but not the Lewis lung, tumour may relate
to the presence of the LDH-elevating virus, and its
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effect to delay the clearance of glutaminase. Even in
mice without tumours, however, injection of glut-
aminase led to substantial reductions in the plasma
level of glutamine for 24h after injection.
If glutaminase exerts therapeutic effects through
reduction of the serim concentration of glutamine,
it might be expected that nutrient-deprived cells in
tumours would be at high risk of cell death due to
reduction of the low level of glutamine in their
environment, and because of cumulative effects due
to deficiency of other nutrients such as oxygen and
glucose. To test this hypothesis, we studied the
effects of glutaminase alone against murine solid
tumours and also with radiation which was used to
selectively deplete the aerobic, well-nourished cell
population. Glutaminase, either alone or used with
radiation, was without effect against Lewis lung
tumours or MGH-Ul xenografts. The enzyme did
cause dose-dependent growth delay of the KHT
tumour, but the magnitude of its effects was not
much greater when added to those of radiation,
than when glutaminase was used alone. This result,
and our experiments using the spheroid model,
suggest that induction of glutamine deficiency is not
likely to be very effective in causing the death of
nutrient-deprived cells in solid tumours.
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